At the heart of our work is a research team committed to the discovery and development of innovative medicines for patients worldwide.
Areas of Focus
ONO is delving into the biology of human disease to discover new therapeutics in each of our four focus areas. Through open innovation, leading-edge informatics, and disease modeling, we aim to advance safe and effective medicines to address unmet patient needs.
Research and Development Driven by Innovation
ONO has a long history of advancing treatment by following where the science leads. Oftentimes this strategy has led the company to important therapeutic advances, like nivolumab, the world’s first anti-PD-1 antibody.
Anti-PD-1 antibody therapies bind to a protein (PD-1) that prevents the body’s T cells from recognizing cancer cells, thereby improving the immune system’s ability to fight cancer.